Publication | Closed Access
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
536
Citations
0
References
2020
Year
VaccinationVaccine SafetyPhase 1/2Vaccine DevelopmentPreliminary ReportImmunologyVaccine EfficacyMedicineChadox1 Ncov-19 VaccineCovid-19
No additional data available for this publication yet. Check back later!